Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:16:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 is displayed on the page, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:21:32.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 instead of Revision: v3.4.0. This is a metadata update at the top of the page and does not affect study content.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:26.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added UI and metadata changes: a Show glossary option appears, and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' are shown. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed or updated.
    Difference
    0.3%
    Check dated 2026-01-28T20:25:19.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4 instead of v3.3.3. This is a metadata update with no visible changes to the study details or layout; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:01:10.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a Locations section showing the Philadelphia, PA site (Abramson Cancer Center of the University of Pennsylvania) and updated the page revision to v3.3.3; removed the older Pennsylvania Locations entry and the HHS Vulnerability Disclosure link (v3.3.2).
    Difference
    0.3%
    Check dated 2025-12-23T21:04:28.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.